Area: Strategy
$52.6 Billion: Extra Cost to Consumers of Add-On Drug Patents
The figure is a subset, not covering huge expense of extended patents on high-priced biologics like Humira
A Broader Measure of Value Creation at Corporations
A tool in the debate over shareholder primacy and wealth disparities
A Case Against Experience as a Central Driver of Innovation
Are older inventors weighed down by obsolete knowledge? Young inventors don’t carry that burden
Academic Medical Centers Resilient After Cuts
Following Medicare reimbursement rate changes, research actually increased
Assessing Climate Disclosure as U.S. Drops Scope 3 Requirement
What emerges is a fragmented view of corporate contribution to global warming
CEO Succession: Execs Running a Subsidiary Offer a Balance Between Insider and Outsider
In an analysis of transitions from 1993 to 2017, they wrung more from operations facing tumult
CEOs Risk Alienating Customers with High-Profile Activism
Taking a stand on controversial issues can hurt sales, but the effect is brief
Consumer Backlash to CEO Advocacy: Signaling or Act of Conscience?
An experiment seeks to isolate motivation and raises concerns for outspoken corporate leaders
Diversity, Economic Growth and a Bug in the Research
Whether research shows benefits from diversity depends heavily on choice of study design
Do Corporate Wellness Programs Boost Worker Productivity?
Industrial laundry gains 4% output; better health and better feelings toward employer could account for increase
Do Hospital Mergers Really Cut Health Care Costs?
Matt Schmitt finds that size and location help determine how much, if any, costs fall after deals
Entrepreneurship, Riskier in Wealthy Nations, Is Actually Safer in India
Steady employment is rare — a condition some U.S. workers also endure
Exploring the Relationship between Off-Label Prescriptions and Clinical Trials
A study looks at how changes in FDA labeling affect pediatric utilization of drugs
Face-to-Face Meetings, Before an Acquisition, Improve Outcomes for Buyers
Acquiring companies appear to get a better deal following frequent in-person meetings
FDA’s Breakthrough Program: Faster Drug OKs Without Sacrificing Safety
Dedicated FDA staff guide companies during design of clinical trials
Gaining Status in an Online Community
How unknown individuals turn into influencers on a platform for programmers